Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Aardvark Therapeutics, Inc. (AARD) had Weighted-Average Shares Outstanding (Diluted) of 21.71M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-16.32M |
|
-- |
|
-- |
|
$17.70M |
|
$-17.70M |
|
$1.39M |
|
$-16.32M |
|
$-16.35M |
|
$-16.32M |
|
$-16.32M |
|
$-16.32M |
|
$-16.35M |
|
$-17.70M |
|
$-18.07M |
|
21.71M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
21.71M |
$-0.75 |
|
$-0.75 |
|
| Balance Sheet Financials | |
$129.21M |
|
-- |
|
$4.02M |
|
$133.23M |
|
$10.74M |
|
-- |
|
$0.12M |
|
$10.85M |
|
$122.38M |
|
$122.38M |
|
$122.38M |
|
21.75M |
|
| Cash Flow Statement Financials | |
$-37.36M |
|
$-73.97M |
|
$88.97M |
|
$61.64M |
|
$39.28M |
|
$-22.36M |
|
$2.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-37.46M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.33% |
|
-13.33% |
|
-12.25% |
|
-13.33% |
|
$5.63 |
|
$-1.73 |
|
$-1.72 |
|